Patents by Inventor Anthony Siadak

Anthony Siadak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060275296
    Abstract: The present invention relates to methods of treating pruritic diseases, including but not limited to Contact dermatitis, Atopic Dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia wereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus, or combination thereof by administering IL-31 monoclonal antibodies. The invention further provides the hybridomas that generate the monoclonal antibodies.
    Type: Application
    Filed: May 8, 2006
    Publication date: December 7, 2006
    Inventors: Anthony Siadak, Janine Bilsborough, Elin Florkiewicz, Aaron Haran, Shirley Rene
  • Publication number: 20060141582
    Abstract: The present invention relates to blocking, inhibiting, reduceing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners.
    Type: Application
    Filed: October 21, 2005
    Publication date: June 29, 2006
    Inventors: Wenfeng Xu, Wayne Kindsvogel, Yasmin Chandrasekher, Stacey Dillon, Joyce Lehner, Anthony Siadak, Pallavur Sivakumar, Margaret Moore
  • Publication number: 20060134756
    Abstract: The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-20 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. The present invention includes anti-IL-20 and anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-20 using such antibodies and binding partners.
    Type: Application
    Filed: March 24, 2004
    Publication date: June 22, 2006
    Inventors: Wenfeng Xu, Wayne Kindsvogel, Yasmin Chandrasekher, Stacey Dillon, Joyce Lehner, Anthony Siadak, Pallavur Sivakumar, Margaret Moore
  • Publication number: 20050170468
    Abstract: The present invention relates to blocking the activity of IL-20 receptor polypeptide molecules. IL-20 is a cytokine that is involved in inflammatory processes and human disease. IL-20RA/IL-20RB is a common receptor for IL-20. The present invention includes anti-IL-20 receptor antibodies and binding partners, including anti-IL-20RA, anti-IL-20RB and anti-IL-20RA/IL-20RB antibodies as well as methods for antagonizing IL-20RA and IL-20RB, either individually or together, using such antibodies and binding partners.
    Type: Application
    Filed: November 19, 2004
    Publication date: August 4, 2005
    Inventors: Wenfeng Xu, Wayne Kindsvogel, Zhi Chen, Steven Hughes, Yasmin Chandrasekher, Stacey Dillon, Joyce Lehner, Anthony Siadak, Pallavur Sivakumar, Margaret Moore
  • Publication number: 20050136004
    Abstract: The present invention relates to blocking the activity of IL-20 polypeptide molecules. IL-20 is a cytokine that is involved in inflammatory processes and human disease. IL-20RA/IL-20RB is a common receptor for IL-20. The present invention includes anti-IL-20 antibodies and binding partners, as well as methods for antagonizing IL-20 using such antibodies and binding partners.
    Type: Application
    Filed: November 19, 2004
    Publication date: June 23, 2005
    Inventors: Wenfeng Xu, Wayne Kindsvogel, Zhi Chen, Steven Hughes, Yasmin Chandrasekher, Stacey Dillon, Joyce Lehner, Anthony Siadak, Pallavur Sivakumar, Margaret Moore